| mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |